Physician profile
Mahesh Mohan
NPI 1417269655
$5,297.57
in general payments reported to CMS, 2019-2025
17 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $2,047 · 2021: $404 · 2022: $1,072 · 2023: $706 · 2024: $326 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211 · Travel and Lodging: $0.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.25 |
| Travel and Lodging | $0.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,942.81 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $1,073.05 | 2019-2020 | |
| Spinal Simplicity, LLC | $544.76 | 2022-2024 | Ha Minuteman G3-R |
| Medtronic, INC. | $518.22 | 2021-2023 | Vanta Adaptivestim |
| Nevro Corp. | $345.99 | 2019-2024 | Senza |
| Abbott Laboratories | $252.25 | 2019-2022 | |
| Spr Therapeutics, INC | $145.93 | 2023-2025 | Sprint Pns System |
| Abbvie INC. | $119.99 | 2024-2025 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $58.41 | 2019 | |
| Collegium Pharmaceutical, INC. | $44.50 | 2019-2022 | |
| Painteq LLC | $38.37 | 2022 | |
| Biodelivery Sciences International, INC. | $33.95 | 2020-2021 | |
| Nalu Medical, INC. | $32.62 | 2025 | Nalu Neurostimulation System |
| Bioventus LLC | $18.96 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $16.06 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahesh Mohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.